MUDr. Roman Košek

Professional education

2009

• Specialised qualification in the field of internal medicine
• Functional licence F016 – Artificial nutrition and metabolic care

1997

• 2nd attestation in internal medicine – Institute of Postgraduate Medical Education, Prague

1992

• 1st attestation in internal medicine – Institute of Postgraduate Medical Education, Prague

1983-1989

• Faculty of Medicine, Charles University Prague

‍

Work experience

since 2019

• Health+

2008-2019

• Head Physician, Department of Internal Medicine, Mladá Boleslav Regional Hospital

2010-2011

• External teacher, 3rd Faculty of Medicine, Charles University Prague

1997-2007

• Assistant head physician, Department of Internal Medicine, Mladá Boleslav Hospital

1989-1996

• Department of Internal Medicine, Mladá Boleslav Hospital - secondary doctor and work at inpatient department of internal medicine and gastroenterology endoscopy department

‍

Membership of professional associations

• Czech Society of Gastroenterology of the Czech Medical Association J.E.Purkyne - member
• Czech Society of Internal Medicine of the Czech Medical Association J.E.Purkyne - member

‍

Participation in research projects

Professional and publishing activities

• 2013 - Study NN2211-3867. Clinical phase 4, comparing the efficacy of liraglutide versus lixisenatide as adjuvant therapy for patients treated with metformin.
• 2010 – Study BI 1245.28, Clinical phase 3, comparing the efficacy and safety of administering product BI 10773 in comparison with glimepiride. Tested substance: BI 10773, selective inhibitor Na-glucose co-transporter 2 (SGLT-2).
• 2010 - Study NN1250-3724 insulin SIBA (soluble insulin basal analogue) in comparison with insulin glargine in patients with type 2 DM, clinical phase 3
• 2009 – Study no. 1218.36, clinical phase 3 linagliptin in combination with basal insulin for type 2 DM
• 2005-2006 Study GWCL 0305, GWCL 0404 (efficacy of sativex in treatment of neuropathic pain in diabetics). Clinical phase 3
• 2003-2005 Study EC 410, EC 404 (pioglitazone plus metformin versus gliclazide plus metformin in the therapy of type 2 diabetes mellitus). Clinical phase 3

‍

Languages skills

• German
• English - passive

‍

Hobbies and interests

• Travelling, cycling, reading